Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
03/2008
03/05/2008CN101134755A Quinazoline(di) ones for invertebrate pest control
03/05/2008CN100372825C 3,4-difluoro-2-methoxyl biphenyl derivative and its preparation process and application
03/04/2008US7338978 Insecticidal anthranilamides
03/04/2008US7338959 N2-isopropyl-N5,1-dimethyl-N5-[2-({4-[(methylsulfonyl)methyl]phenyl}amino)pyrimidin-4-yl]-1H-benzimidazole-2,5-diamine; vascular endothelial growth factor (VEGF) receptor-2 and tyrosine kinase containing Ig and EGF homology domains (TIE) -2 inhibitor; antiproliferation and antihypoxic agent
03/04/2008US7338958 Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agents
02/2008
02/28/2008WO2008024634A1 Pyrimdine compounds useful as kinase inhibitors
02/28/2008WO2008023357A1 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr)
02/28/2008WO2008023180A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
02/28/2008WO2008023159A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
02/28/2008US20080051424 Heterocyclyl-substituted nonadepsipeptides
02/28/2008US20080051412 Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds and their Uses
02/28/2008US20080051404 Heteroaryl compounds useful as inhibitors of E1 activating enzymes
02/28/2008US20080051401 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer
02/28/2008US20080051399 Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
02/28/2008US20080051395 2-Pyrimidinyl Pyrazolopyridine Erbb Kinase Inhibitors
02/28/2008US20080051384 Antiviral agents
02/28/2008CA2661307A1 Heterocyclic derivatives binding to the peripheral-type benzodiazepine receptor (pbr)
02/28/2008CA2661223A1 4-aminoquinazoline derivatives and methods of use thereof
02/27/2008EP1892245A2 Antineoplastic compounds and pharmaceutical compositions thereof
02/27/2008EP1891021A1 Aspartyl protease inhibitors
02/27/2008EP1891020A2 Processes for the preparation of azoxystrobin using dabco as a catalyst and novel intermediates used in the processes
02/27/2008EP1891019A2 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists
02/27/2008EP1891018A2 Modulators of atp-binding cassette transporters
02/27/2008EP1890703A2 Pyrimidine compounds
02/27/2008EP1890697A2 Azinone and diazinone v3 inhibitors for depression and stress disorders
02/27/2008EP1789014B1 Substance for dyeing keratinic fibers
02/27/2008EP1446115B1 Cyanoalkylamino derivatives as protease inhibitors
02/27/2008EP1248612B1 Novel compounds and compositions as protease inhibitors
02/27/2008CN101133038A HIV inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines
02/27/2008CN101130542A Synthesis method of antiviral nucleoside analogue
02/27/2008CN101130521A Novel pyrimidine derivative with obvious biological activity
02/27/2008CN100371329C Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases
02/27/2008CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
02/27/2008CN100370975C Inhibitors against the production and releaseof inflammator cytokines
02/27/2008CA2660758A1 Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
02/26/2008US7335672 Vanilloid receptor ligands and their use in treatments
02/26/2008US7335663 Heteroaryl compounds which inhibit leukocyte adhesion mediated by α4 integrins
02/26/2008US7335662 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 4-(4-pyrimid-2-ylaminosulfonyl-1,4-phenylene-aminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole
02/26/2008US7335659 Substituted 10-aryl-11H-benzo[b]fluorenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors
02/26/2008US7335657 Cytokine inhibitors
02/21/2008WO2008020711A1 Quinazoline derivative as phosphodiesterase inhibitor and a process for preparing the same
02/21/2008WO2008020425A1 Crystalline moxonidine comprising single tautomer and preparation process therefor
02/21/2008WO2007146981A3 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha
02/21/2008WO2007103456A3 Piperazine and piperidine biaryl derivatives
02/21/2008WO2007010222A3 Therapeutic agents
02/21/2008US20080045712 Process for Preparing 4-Aminopyrimidine Compound
02/21/2008US20080045710 Chemotherapeutic compounds for selectively targeting tumor cells with FR type receptors
02/21/2008US20080045555 hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors; avoiding adverse effects such as hepatotoxicity and cutaneous flushing; low dosage; 2-bromo-8-methyl-4-pentyl-1,4-dihydro-5H-[1,2,4]triazolo[5,1-i]purin-5-one; to treat cardiovascular disorders
02/21/2008US20080045554 hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors; avoiding adverse effects such as hepatotoxicity and cutaneous flushing; low dosage; 2-bromo-8-methyl-4-pentyl-1,4-dihydro-5H-[1,2,4]triazolo[5,1-i]purin-5-one; to treat cardiovascular disorders
02/21/2008US20080045550 [1-(4-chloro-3-ethoxy-benzyl)-piperidin-4-yl]-(2-chloro-pyrimidin-4-yl)-amine; somatostatin receptor subtype 5 (SSTR5) antagonists; diabetes mellitus
02/21/2008US20080045546 Tetradydro-Naphthalene And Urea Derivatives
02/21/2008US20080045535 Prokineticin 2 receptor antagonists
02/21/2008US20080045529 Use Of Thienopyrimidines
02/21/2008US20080045517 Such as {(2S)-2-[2-[2-(7-azabicyclo[2.2.1]hept-7-yl)-1,1-dimethyl-2-oxoethyl]-5-(3,5-dimethylphenyl)-6H-thieno[2,3-b]pyrrol-4-yl]propyl}(2-pyridin-4-ylethyl)amine for treating sex hormone related prostate cancer and pre-menopausal breast cancer
02/21/2008US20080045516 Viral Polymerase Inhibitors
02/21/2008US20080045500 Nerve Regeneration Stimulator
02/21/2008US20080044379 (1R)-2-((2S)-2-(5-(6-(4-(2-((2S)-1-((2R)-2-(dimethylamino)-2-phenylacetyl)-2-pyrrolidinyl)-1H-imidazol-5-yl)phenyl)-3-pyridinyl)-1H-imidazol-2-yl)-1-pyrrolidinyl) -N,N-dimethyl-2-oxo-1-phenylethanamine; inhibit the function of the non-structural proteins (NS5A)
02/21/2008CA2660659A1 Preparation and utility of substituted quinazoline compounds with alpha-adrenergic blocking effects
02/21/2008CA2658843A1 Crystalline antifungal compounds
02/20/2008EP1889845A1 Novel pleuromutilin derivatives
02/20/2008EP1889836A1 Novel pyridine derivative and pyrimidine derivative (3)
02/20/2008EP1888538A1 (3,4-dihydro-quinazolin-2-yl)-(2-aryloxy-ethyl)-amines having an activity on the 5-ht receptor
02/20/2008EP1888537A1 Process for preparing 4-[(1,6-dihydro-6-oxo-2-pyrimidinyl)amino benzonitrile
02/20/2008EP1888536A1 Method for preparing substituted pyrimidines
02/20/2008EP1888535A1 New heterocyclylethylbenzamide derivatives
02/20/2008EP1888534A2 Organic compounds
02/20/2008EP1888518A1 Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor
02/20/2008EP1888509A1 Benzoyl-substituted serine amides
02/20/2008EP1383747B1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
02/20/2008EP1289968B1 Cyclic urea compounds and preparation thereof
02/20/2008CN101128441A Fused aromatic compounds having anti-diabetic activity
02/20/2008CN101128438A Substituted 1,1,1-trifluoro-3-[(benzyl)-(pyrimidin-2-yl)-amino]-prop an-2-ol compounds
02/20/2008CN101128437A Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof
02/20/2008CN101128436A 甘氨酸衍生物及其用途 Glycine derivatives and their use
02/20/2008CN101128199A Monocyclic heterocycles as kinase inhibitors
02/20/2008CN101125138A Inhibitors against the production and release of inflammatory cytokines
02/20/2008CN100369888C N-alkanoylphenylalanine derivatives
02/19/2008US7332514 Dibenzylamine compound and medicinal use thereof
02/19/2008US7332511 Vanilloid receptor ligands and their use in treatments
02/19/2008US7332509 Used for controlling animal pests, in particular arthropods, such as insects and acarids, and helminths
02/19/2008US7332499 N-[(1R)-1-(2-fluoro-4-{1-[(trifluoromethyl)sulfonyl]-1,2,3,4-tetrahydroquinolin-8-yl}phenyl)ethyl]-1-[(trifluoroacetyl)amino]cyclopropanecarboxamide; bradykinin B1 antagonists or inverse agonists; analgesic and antiinflammatory agent; acute and chronic pain
02/19/2008US7332493 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma
02/19/2008US7332487 Nitrogen-containing 5-membered ring compound
02/19/2008US7332485 Peptide deformylase inhibitors
02/19/2008US7332484 2,4-pyrimidinediamine compounds and their uses
02/19/2008US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease
02/19/2008CA2328927C Benzamide derivatives for the treatment of diseases mediated by cytokines
02/19/2008CA2207100C Pyrimidine derivatives
02/19/2008CA2206366C Substituted 2-naphthoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
02/14/2008WO2008019124A1 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
02/14/2008WO2008018544A1 Sulfonamide compound or salt thereof
02/14/2008WO2008018306A1 Quinazoline derivative
02/14/2008WO2007018248A9 Pyridone compound
02/14/2008US20080039622 2,4-pyrimidinediamine compounds and their uses
02/14/2008US20080039480 Quinazolinedione Derivatives as Parp Inhibitors
02/14/2008US20080039479 Compounds and therapeutical use thereof
02/14/2008US20080039458 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine
02/14/2008US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents
02/14/2008US20080039446 Substituted isoindoles and their use
02/14/2008CA2660424A1 Sulfonamide compound or salt thereof